Adverse events induced by immune checkpoint inhibitors.

Abstract excerpt

Immune checkpoint inhibitors have revolutionized the treatments of cancers but are also associated with immune related adverse events that can interfere with their use. The types and severity of adverse events vary with checkpoint inhibitors. A single mechanism of pathogenesis has not emerged: postulated mechanisms involve direct effects of the checkpoint inhibitor, emergence of autoantibodies or autoreactive T...

Topics

Share this publication in a Topic to start or enrich a Post.

• Share to Autoantibodies
• Share to Autoantigens
• Share to Autoimmune Diseases